Financial Consulate’s Neurogene NGNE Stock Holding History

Financial Consulate’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$696	Buy	+25	New	+$891	﹤0.01%	1379

Other funds holding NGNE

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Financial Consulate's NGNE Position: Q3 2026 in Review

Financial Consulate opened a new position in Neurogene (NGNE) in Q3 2026: 25 shares worth $696. The stake represents ﹤0.01% of the portfolio and ranks #1379 among its holdings.

12 funds tracked by Wall St. Rank hold NGNE as of Q3 2026.

Financial Consulate held 25 shares of Neurogene worth $696 as of Q3 2026.
Neurogene was a new Financial Consulate position in Q3 2026.
Neurogene made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1379 holding.
12 funds tracked by Wall St. Rank held Neurogene as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.